Pancreatic Cancer Research

ResearcherCentre National de la Recherche ScientifiqueActive in the last 2 years

Jérôme Torrisani

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6880-9357; OpenAlex author ID A5026644679. Sources: OpenAlex.

Their work

Papers
14 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
30
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 3 papers · 2014: none · 2015: 4 papers · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 2 papers · 2022: 1 paper · 2023: none · 2024: 3 papers

Papers 14

  1. Predictive genomic and transcriptomic analysis on endoscopic ultrasound-guided fine needle aspiration materials from primary pancreatic adenocarcinoma: a prosp… Co-author DOI 10.1016/j.ebiom.2024.105373↗
  2. Cytidine deaminase-dependent mitochondrial biogenesis as a potential vulnerability in pancreatic cancer cells. Co-author DOI 10.1038/s42003-024-06760-y↗
  3. Cytidine Deaminase Resolves Replicative Stress and Protects Pancreatic Cancer from DNA-Targeting Drugs. Co-author DOI 10.1158/0008-5472.can-22-3219↗
  4. Cytidine deaminase regulates mitochondrial biogenesis in pancreatic cancer cells Co-author DOI 10.1101/2022.12.15.520429↗
  5. Pancreatic Ductal Adenocarcinoma Arising in Young and Old Patients Displays Similar Molecular Features. Co-author DOI 10.3390/cancers13061234↗
  6. Antagonistic Roles of the Tumor Suppressor miR-210-3p and Oncomucin MUC4 Forming a Negative Feedback Loop in Pancreatic Adenocarcinoma. Co-author DOI 10.3390/cancers13246197↗
  7. Micro-RNAs miR-29a and miR-330-5p function as tumor suppressors by targeting the MUC1 mucin in pancreatic cancer cells. Co-author DOI 10.1016/j.bbamcr.2015.05.033↗
  8. First-in-man phase 1 clinical trial of gene therapy for advanced pancreatic cancer: safety, biodistribution, and preliminary clinical findings. Co-author DOI 10.1038/mt.2015.1↗
  9. miR-219-1-3p is a negative regulator of the mucin MUC4 expression and is a tumor suppressor in pancreatic cancer. Co-author DOI 10.1038/onc.2014.11↗
  10. Salivary MicroRNA in Pancreatic Cancer Patients. Co-author DOI 10.1371/journal.pone.0130996↗
  11. miRNA in clinical practice: pancreatic cancer. First author DOI 10.1016/j.clinbiochem.2013.03.019↗
  12. [Kras oncogene and pancreatic cancer: thirty years after]. Co-author DOI 10.1051/medsci/20132911015↗
  13. The rescue of miR-148a expression in pancreatic cancer: an inappropriate therapeutic tool. Last author DOI 10.1371/journal.pone.0055513↗
  14. Molecular endoscopic ultrasound for diagnosis of pancreatic cancer. Co-author DOI 10.3390/cancers3010872↗

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Pierre Cordelier · 9 shared papers, 2011–2024 · strength 0.72
  2. Louis Buscail · 8 shared papers, 2011–2024 · strength 0.66
  3. Naïma Hanoun · 5 shared papers, 2013–2024 · strength 0.53
  4. Marion Gayral · 4 shared papers, 2015–2024 · strength 0.50
  5. Audrey Lumeau · 3 shared papers, 2022–2024 · strength 0.46
  6. Audrey Francès · 3 shared papers, 2022–2024 · strength 0.46
  7. Nelson Dusetti · 3 shared papers, 2022–2024 · strength 0.46
  8. Fatima Lahdaoui · 3 shared papers, 2015–2021 · strength 0.23
  9. Isabelle VAN SEUNINGEN · 3 shared papers, 2015–2021 · strength 0.23
  10. Nicolas Jonckheere · 3 shared papers, 2015–2021 · strength 0.23
  11. Yannick Delpu · 4 shared papers, 2011–2015 · strength 0.17
  12. Barbara Bournet · 4 shared papers, 2011–2015 · strength 0.16
  13. Abdessamad El Kaoutari · 1 shared paper, 2024 · strength 0.15
  14. Guillaume Labrousse · 1 shared paper, 2024 · strength 0.15
  15. Nihad Boukrout · 1 shared paper, 2021 · strength 0.13
  16. Marine Humeau · 2 shared papers, 2013–2015 · strength 0.11
  17. Rémy Nicolle · 1 shared paper, 2021 · strength 0.10
  18. Magali Svrcek · 1 shared paper, 2021 · strength 0.10
  19. Vinciane Rebours · 1 shared paper, 2021 · strength 0.10
  20. Jerome F. Cros · 1 shared paper, 2021 · strength 0.10
  21. Jérôme Raffenne · 1 shared paper, 2021 · strength 0.10
  22. Anne Couvelard · 1 shared paper, 2021 · strength 0.10
  23. Francesco Puleo · 1 shared paper, 2021 · strength 0.10
  24. Valérie Paradis · 1 shared paper, 2021 · strength 0.10
  25. Pascal R. Hammel · 1 shared paper, 2021 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.